Sinocelltech Group Limited (SHA:688520)

China flag China · Delayed Price · Currency is CNY
41.28
+1.37 (3.43%)
Mar 28, 2025, 2:44 PM CST
1.98%
Market Cap 18.35B
Revenue (ttm) 2.51B
Net Income (ttm) 111.95M
Shares Out 445.34M
EPS (ttm) 0.25
PE Ratio 164.84
Forward PE 34.34
Dividend n/a
Ex-Dividend Date n/a
Volume 5,689,424
Average Volume 2,598,666
Open 39.87
Previous Close 39.91
Day's Range 39.77 - 43.15
52-Week Range 31.07 - 52.60
Beta 0.61
RSI 60.37
Earnings Date Apr 26, 2025

About Sinocelltech Group

Sinocelltech Group Limited, a biotech company, engages in the research and development, and industrialization of recombinant proteins, monoclonal antibodies, and innovative vaccines in China. The company offers Anpingxi an antibody drug and anti-tumor product; Anjiayin for the treatment of the rare disease hemophilia A; coronavirus 2-valent, a trimer protein vaccine; and mutant strain recombinant protein vaccines SCTV01C and SCTV01E. Its pipeline products include SCT630 used for the treatment of autoimmune diseases; SCT510 for the treatment of ... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2007
Employees 2,313
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688520
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.